Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Group letter urging Secretaries Becerra, Su, and Yellen to ensure that any revision of the cost-sharing rule related to copay accumulator adjustment policies includes clear, commonsense protections guaranteeing that copayments made by or on behalf of an enrollee are counted as payments toward their annual cost-sharing contributions. The letter also request a meting on this topic at their earliest convenience.
Group letter commenting on the FY2025 Inpatient Prospective Payment System (IPPS) and Long Term Care Hospital (LTCH) Prospective Payment System Proposed Rules.
CSC letter supporting the Nancy Sewell Gardner Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407) and urging the passage of the amended bill out of the U.S. House Committee on Ways & Means.
Group letter to the DoL, DHHS, and DoT commenting on the new Notice of Benefit Payment Parameters (NBPP) and Alternative Funding Program (AFP) rules to provide the greatest protections possible to health insurance enrollees in large group and self-insured plans.
Group letter to the Maryland Prescription Drug Affordability Board (PDAB) explaining the realities of treating chronic conditions and outlining why therapeutic alternatives are not always applicable to patients.
Group letter urging the Education & Workforce Committee to mark up the Safe Step Act in response to the ERISA 50th anniversary hearing.
CSC-led sign on letter to CMS providing feedback on CMS' Part C and Part D Medicare Prescription Payment Plan (M3P) model documents
Group letter to CMS commenting on the Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents.
Group letter to House and Senate leadership requesting a meeting with congressional offices to share patients perspectives and priorities re (1) improving and expanding access to high quality, affordable, insurance coverage, (2) reducing the burden of medical debt on patients, and (3) protecting patients by limiting junk insurance.
Group letter applauding newly released final rule on Section 1557 of the ACA that will strengthen non-discrimination protections in health care.